WINNERS & LOSERS: Allergy Therapeutics shares plunge on AIM exit plan
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday. Read More
| Price | 12.75p on 13-11-2026 at 19:35:12 |
|---|---|
| Change | -0.25p -1.92% |
| Buy | 13.00p |
| Sell | 12.50p |
| Last Trade: | Sell 53.00 at 12.50p |
| Day's Volume: | 153,984 |
| Last Close: | 12.75p |
| Open: | 13.00p |
| ISIN: | GB00BFXR4C20 |
| Day's Range | 12.75p - 13.00p |
| 52wk Range: | 6.625p - 16.50p |
| Market Capitalisation: | £27.92m |
| VWAP: | 12.7275p |
| Shares in Issue: | 218.97m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Ixico (IXI) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 53 | 12.50p | Ordinary |
16:12:55 - 13-Nov-26 |
| Buy* | 23 | 13.00p | Ordinary |
16:03:01 - 13-Nov-26 |
| Sell* | 50 | 12.50p | Ordinary |
15:55:17 - 13-Nov-26 |
| Buy* | 286 | 13.00p | Ordinary |
15:47:38 - 13-Nov-26 |
| Sell* | 50 | 12.50p | Ordinary |
15:38:08 - 13-Nov-26 |
| Sell* | 50 | 12.50p | Ordinary |
15:32:04 - 13-Nov-26 |
| Sell* | 211 | 12.50p | Ordinary |
15:25:10 - 13-Nov-26 |
| Buy* | 61 | 13.00p | Ordinary |
15:22:25 - 13-Nov-26 |
| Buy* | 19,519 | 12.79p | Ordinary |
15:17:16 - 13-Nov-26 |
| Sell* | 125 | 12.50p | Ordinary |
15:13:29 - 13-Nov-26 |
Ixico (IXI) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 2nd Nov 2026 7:00 am | RNS | £2.7m clinical phase 3 contract win |
| 29th Oct 2026 7:00 am | RNS-R | IXICO Presents New Huntington's Disease Research |
| 22nd Oct 2026 7:00 am | RNS | Alzheimer's contract wins |
| 20th Oct 2026 7:00 am | RNS | Trading Update |
| 1st Oct 2026 7:00 am | RNS-R | IXICO present PD research at radiology conference |
| 27th Jul 2026 2:46 pm | RNS | Share option award |
| 15th Jul 2026 12:01 pm | RNS | Director/PDMR Shareholding |
| 13th Jul 2026 7:00 am | RNS | HD Industry Update |
| 7th Jul 2026 7:00 am | RNS | Trading Update |
| 19th Jun 2026 7:00 am | RNS | Exercise of Options |